TrialWire™ was engaged to rescue recruitment for this global IBS trial.

TrialWire™ was activated when recruitment stalled across all sites. The sponsor and CRO were using traditional recruitment methods including social media, advertising, and site databases which were not delivering.

The campaign launched with a series of news article features (no IRB/EC approvals required) in national magazines and online media.

All patent engagement activity was funneled through the Platform so patients could be quickly online screened and connected to their nearest site for follow-up.

The study was fully recruited.

The drug is now approved and on market.